Liraglutide effects on glycemic control and weight in patients with type 2 diabetes Mellitus: A real-world, observational study and brief narrative review
Open Access
- 1 July 2021
- journal article
- review article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 177, 108871
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Effectiveness and Persistence of Liraglutide Treatment Among Patients with Type 2 Diabetes Treated in Primary Care and Specialist Settings: A Subgroup Analysis from the EVIDENCE Study, a Prospective, 2-Year Follow-up, Observational, Post-Marketing StudyAdvances in Therapy, 2017
- A review of glycemic efficacy of liraglutide once daily in achieving glycated hemoglobin targets compared with exenatide twice daily, or sitagliptin once daily in the treatment of type 2 diabetesSaudi Medical Journal, 2016
- Treatment Outcomes and Tolerability Following Initiation of GLP-1 Receptor Agonists Among Type 2 Diabetes Patients in Primary Care Practices in GermanyJournal of Diabetes Science and Technology, 2016
- Long-term efficacy of liraglutide in Indian patients with Type 2 diabetes in a real-world settingIndian Journal of Endocrinology and Metabolism, 2016
- The Effect of Glucagon-Like Peptide 1 Receptor Agonists on Weight Loss in Type 2 Diabetes: A Systematic Review and Mixed Treatment Comparison Meta-AnalysisPLOS ONE, 2015
- Liraglutide: A Review of Its Use in the Management of ObesityDrugs, 2015
- Correlation Between Baseline Characteristics and Clinical Outcomes in a Large Population of Diabetes Patients Treated with Liraglutide in a Real-World Setting in ItalyClinical Therapeutics, 2015
- Predictors of response to liraglutide in Japanese type 2 diabetesDiabetes Research and Clinical Practice, 2014
- Liraglutide: A review of its therapeutic use as a once daily GLP-1 analog for the management of type 2 diabetes mellitusIndian Journal of Endocrinology and Metabolism, 2011
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studiesThe Lancet, 2010